MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG)
MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) Drug alert number: EL(26)A/39 Date issued: 23 September 2026 B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg [...]
The post MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) appeared first on Community Pharmacy England.
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest